Two major United States racing companies have restated their support for uniform equine medication and drug testing but have stopped short of endorsing an effort to pass federal legislation that would give USADA oversight.
More than 300 representatives from 27 countries will converge upon New York City for two days of business presentations focusing on the sport of Thoroughbred racing as part of the Pan American Conference.
The operator of Meadowlands, which primarily offers Standardbred racing, said June 1 he supports a lawmaker's plan to introduce legislation in Congress that would provide oversight of equine medication and drug testing.
The National HBPA, which has about 30 affiliate horsemen's groups and about 30,000 members, said May 29 said it has questions regarding a federal lawmaker's plan to introduce legislation to regulate drug rules and testing.
Racing New South Wales announced earlier in May that it has strengthened its drug detection processes by purchasing AUS$1.5 million in new equipment able to screen for more than 8,000 different types of drugs.
Two members of Congress, on the eve of two of Thoroughbred racing's biggest days, announced introduction of legislation that would end interstate simulcasts to encourage racing to end what they call widespread cheating.
Racetrack veterinarians told the Ohio State Racing Commission April 28 they support uniform medication policies, but because their top priority is the welfare of the racehorse, the state's rules should remain in place.
Mark Lamberth, a member of the Arkansas Racing Commission, took over as chairman of the Association of Racing Commissioners International April 23 during the organization's annual convention in Tampa, Fla.
The Association of Racing Commissioners International will put out for comment a broad equine welfare proposal that would sanction anyone found to have used excessive amounts of substances to the detriment of racehorses.
The Association of Racing Commissioners International board of directors April 23 approved a testing threshold level and penalties for the mineral cobalt, a naturally occurring substance in racehorses.
The Arizona Department of Racing is looking into a possible cause for abnormal test results involving seven different racehorses that were euthanized during the current Turf Paradise 2014-15 meet, officials said April 7.
Racing industry officials said they again expect to see federal legislation filed this year that would authorize the United States Anti-Doping Agency to oversee equine medication and drug testing procedures.
Lenny Shulman reflects on Allen Jerkens, California Chrome, and talks with bloodstock agent Donato Lanni. Lanni, who was buying agent for Dortmund, explains what he looks for at sales. Presented by Hill 'n' Dale Stallions
A review of federal court records outlining the criminal cases against four Penn National veterinarians reveals that the vets alledgedly followed the trainers' orders on what medications should be administered to horses.
In a move that sounded a lot like the other shoe dropping, federal criminal charges have been filed against four racetrack veterinarians involved in treating horses at Penn National Race Course near Grantville, Pa.
The New York State Gaming Commission and New York Racing Association March 24 said they have established standing security protocols for horses racing in grade 1 races with purses of $1 million or more.
Trainer Tevis McCauley will have to answer to multiple charges, including allegations of "milkshaking" and medication rule violations, following an investigation by Kentucky Horse Racing Commission staff.
The Kentucky Horse Racing Commission March 23 approved a regulation that would permit the state's racetracks to card races that would prohibit the administration of furosemide within 24 hours of post time.
Setting the testing threshold for cobalt chloride has become the challenge of racing regulators. North American racing has been well behind in its application of a satisfactory testing threshold applied across all states.
With the large concentration of graded stakes scheduled for spring and summer, The Jockey Club is reminding regulators and racetracks that it has budgeted another $250,000 in grants for out-of-competition testing.
As the Ohio State Racing Commission begins a comprehensive review of its medication rules and examines the National Uniform Medication Program, it has a hired a longtime veterinarian to consult on policies and procedures.
The Racing Medication and Testing Consortium may be close to recommending policy on the endogenous element cobalt, which when administered in high doses is believed to enhance production of red blood cells.
The Indiana Horse Racing Commission March 10 upheld an administrative law judge's order that trainer Tom Amoss be suspended 60 days and fined $5,000 in a therapeutic medication case that has dragged on for three years.
A group of prominent organizations involved in Thoroughbred breeding, racing, and sales in North America issued a joint statement Feb. 24 in reaction to the British Horseracing Authority's enhanced equine anti-doping rules.
A provision voiding the claim of a horse placed on the veterinarian's list for bleeding was approved for a 45-day public comment period by the California Horse Racing Board, though members expressed their concerns.